230 related articles for article (PubMed ID: 17310266)
1. Breast cancer leptomeningeal metastasis--the role of multimodality treatment.
Rudnicka H; Niwińska A; Murawska M
J Neurooncol; 2007 Aug; 84(1):57-62. PubMed ID: 17310266
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
3. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival.
Chen TW; Jan IS; Chang DY; Lin CH; Chen IC; Chen HM; Cheng AL; Lu YS
J Neurooncol; 2020 May; 148(1):165-172. PubMed ID: 32346837
[TBL] [Abstract][Full Text] [Related]
6. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
[TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature.
Kapke JT; Schneidewend RJ; Jawa ZA; Huang CC; Connelly JM; Chitambar CR
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):189-193. PubMed ID: 31629723
[TBL] [Abstract][Full Text] [Related]
9. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
Boogerd W; van den Bent MJ; Koehler PJ; Heimans JJ; van der Sande JJ; Aaronson NK; Hart AA; Benraadt J; Vecht ChJ
Eur J Cancer; 2004 Dec; 40(18):2726-33. PubMed ID: 15571954
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
12. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
[TBL] [Abstract][Full Text] [Related]
14. Treatment for meningeal carcinomatosis in breast cancer.
Yap HY; Yap BS; Rasmussen S; Levens ME; Hortobagyi GN; Blumenschein GR
Cancer; 1982 Jul; 50(2):219-22. PubMed ID: 6177395
[TBL] [Abstract][Full Text] [Related]
15. [Leptomeningeal carcinomatous metastases].
Mauro A
Minerva Med; 1984 May; 75(22-23):1395-9. PubMed ID: 6547214
[TBL] [Abstract][Full Text] [Related]
16. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
17. [Three Cases of Intrathecal Chemotherapy with Ventricular Catheter for the Treatment of Leptomeningeal Metastasis from Breast Cancer].
Miyoshi K; Takahashi H; Uno M; Akai M; Moriyama E; Nakagawa T; Nomura T
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1767-1769. PubMed ID: 30587738
[TBL] [Abstract][Full Text] [Related]
18. Outcomes, responses, and prognostic analyses of intrathecal combined treatment for leptomeningeal metastasis from lung adenocarcinoma.
Huang S; Kang X; Wang C; Zhang W; Jiang J; Kang Z; Yang S; Chen J; Chen F; Li W
J Cancer Res Ther; 2024 Apr; 20(2):658-664. PubMed ID: 38687937
[TBL] [Abstract][Full Text] [Related]
19. Management of leptomeningeal malignancy.
Pentheroudakis G; Pavlidis N
Expert Opin Pharmacother; 2005 Jun; 6(7):1115-25. PubMed ID: 15957966
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
Yoshida S; Morii K
Surg Neurol; 2005 Jan; 63(1):52-5; discussion 55. PubMed ID: 15639526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]